Lycolate 0.2mg Injection
Marketer
Biomiicron Pharmaceuticals
Salt Composition
Glycopyrrolate (0.2mg/1ml)
Overview Lycolate 0.2mg Injection
Glycopyrrolate injection (0.2mg) belongs to the anticholinergic class of drugs. Its primary use is pre- or intra-operative reduction of secretions, and it counteracts the neuromuscular blocking effects of certain surgical anesthetics. It's also indicated for peptic ulcers in patients unable to take oral medication. Administration is by a physician or nurse. Complete disclosure of all concurrent medications is crucial, as interactions are possible. Continue treatment as directed; premature cessation may lead to symptom recurrence and disease exacerbation. Common adverse effects include xerostomia, urinary hesitancy, visual blurring, photosensitivity, mydriasis, cycloplegia, tachycardia, elevated intraocular pressure, bradycardia, palpitations, and decreased perspiration. Alcohol consumption should be avoided due to potential additive sedative effects. Consult your doctor if you have glaucoma, myasthenia gravis, congestive heart failure, or hypertension.
Uses of Lycolate 0.2mg Injection
Total Anesthesia | Gastric and Duodenal Ulceration
Major Benefits of Lycolate 0.2mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Lycolate 0.2mg Injection:
- Urinary retention
- Blurred vision
- Dilatation of pupil
- Cycloplegia (paralysis of the ciliary muscle of the eye)
- Ocular hyperemia
- Slow heart rate
- Palpitations
- Reduced sweating
- Increased heart rate
- Increased intraocular pressure
How to use Lycolate 0.2mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Lycolate 0.2mg Injection works:
An injection of 0.2mg Lycolate, an anticholinergic agent, inhibits the action of acetylcholine, a neurotransmitter, within the central nervous system.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Lycolate 0.2mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The administration of Lycolate 0.2mg Injection during gestation is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful consequences to offspring; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Lycolate 0.2mg Injection during lactation appears to pose minimal risk. Available human data indicate negligible infant exposure. However, prolonged use of Lycolate 0.2mg Injection may decrease breast milk supply.
DrivingUNSAFE
Administration of Lycolate 0.2mg Injection may induce adverse reactions impacting driving capabilities. Lycolate 0.2mg Injection can impair vision and coordination, potentially compromising driving safety.
KidneyCAUTION
Administering Lycolate 0.2mg Injection to individuals with impaired renal function requires careful consideration. Dosage modification of Lycolate 0.2mg Injection might be necessary. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Lycolate 0.2mg Injection to individuals with hepatic impairment. Physician consultation is recommended.
What if you forget to take Lycolate 0.2mg Injection :
NA
Facts to Know About Lycolate 0.2mg Injection
| Label | Value |
|---|---|
| Chemical Category | Quaternary Ammonium Compounds |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Actions | Anesthesia and Anticholinergic Drugs |
3,018 People bought this recently